The American Association for the Study of Liver Disease guidelines recommended the use of periodic examination of serum alpha-fetoprotein (AFP) levels and abdominal ultrasound scans as the main screening tools for early detection of HCC in chronic liver disease patients, but the accuracy and usefulness of these tests remain questionable [6]. This evidence concerns the gene AFP and liver disorder.